Brighter enters into commercial collaboration agreement with VivBon AB in Sweden for the Actiste® portfolio

Brighter AB (publ) (“Brighter” or “the Company”) announced today that the company has entered into a commercial collaboration agreement with VivBon AB,a Swedish service provider that offers a wide range of personalized services and solutions for seniors and their relatives, to sell Brighter’s Actiste® and Actiste® Mini portfolio for diabetes management. Under this collaboration agreement, Vivbon will actively offer and sell Actiste® and Actiste® Mini to its customers. With this collaboration, Brighter will expand its active user base in Sweden and gain additional insights and data on user experience. The company does not expect any significant revenues from the collaboration.

“We are very pleased to be partnering with VivBon and expand Brighter’s sales channels in Sweden. The purpose is primarily to increase the number of active users in Sweden to generate further insights into the use with the goal of contributing to even better diabetes care, which is expected to support sales efforts in other markets and contribute to continued product development in the future,” commented Christer Trägårdh, Chairman of the Board of Brighter.

Actiste® and Actiste® Mini form the basis of the company's offering developed with a vision to increase the quality of life for people living with diabetes. Further information about the solutions is available via https://actiste.com/.

For further information, please contact:

Investor Relations
IR@brighter.se

Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10,
adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research.Brighters kvalitetsledningsystem är ISO-13485-certifierat. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

For more information, please visit our website via the following link: https://brighter.se/